Literature DB >> 2020001

5-HT1A-sensitive adenylyl cyclase of rodent hippocampal neurons: effects of antidepressant treatments and chronic stimulation with agonists.

A Varrault1, V Leviel, J Bockaert.   

Abstract

The effects of chronic treatment with desimipramine (a tricyclic antidepressant), fluoxetine [a specific 5-hydroxytryptamine (5-HT) uptake inhibitor], clorgyline (a specific monoamine oxydase inhibitor of A type), ipsapirone (a specific 5-HT1A receptor agonist) as well as electroconvulsive shock treatment were investigated on rat hippocampal 5-HT1A receptors negatively coupled to adenylyl cyclase. Drugs were injected intraperitoneally in rats for 2 or 3 weeks, and biochemical determinations were made 4 to 72 hr after the final dose. Chronic treatments with desimipramine, ipsapirone and fluoxetine did not induce any change in the 5-HT1A-induced inhibition of the adenylyl cyclase activity. In contrast, chronic treatment with clorgyline and electroconvulsive shock treatment induced a slight but significant reduction of 5-HT's ability to inhibit hippocampal adenylyl cyclase. This indicates that, at least in hippocampal neurons, the 5-HT1A receptor coupled to adenylyl cyclase is not easily desensitized. This was verified in vitro on murine hippocampal neurons in culture, by measuring the effects of intense stimulation (1 and 2 hours), with 5-HT, ipsapirone and 8-hydroxy-2-(di-n-propylamino)tetralin. Indeed, such stimulations did not significantly affect the 5-HT1A receptor-induced inhibition of cAMP production in these hippocampal neurons in culture. Our results indicate that it is not the post-synaptic 5-HT1A receptor of hippocampus that is modified during antidepressant treatments, at least at the level of its coupling to adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020001

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration.

Authors:  J Hensler; H Durgam
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Delayed effects of spiperone on serotonin1A receptors in the dorsal hippocampus of rats.

Authors:  T Dennis; P Blier; C de Montigny
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

3.  Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.

Authors:  I K Wright; M Heaton; N Upton; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Regional central serotonin receptor binding in rats treated chronically with high-dose 5-hydroxy-L-tryptophan.

Authors:  M R Pranzatelli
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 5.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

6.  Adaptive changes in 5-HT1A receptor-mediated hippocampal inhibition in the alert rat produced by repeated 8-OH-DPAT treatment.

Authors:  D Manahan-Vaughan; R Anwyl; M J Rowan
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

7.  Enhancement of cyclic AMP accumulation mediated by 5-HT after chronic amitriptyline treatment in NG 108-15 cells.

Authors:  M Shimizu; A Nishida; H Fukuda; H Saito; S Yamawaki
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

Review 8.  What Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells?

Authors:  Paulina S Rojas; Jenny L Fiedler
Journal:  Front Cell Neurosci       Date:  2016-11-24       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.